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Background
Regulatory T cells (Tregs) suppress the induction of
immune response to cancer cells. An increased number
of Tregs have been observed in many solid tumors. The
aim of this study was to evaluate whether the number
and percentage of circulating Tregs and their subpopu-
lations differ in patients with gastric cancer (GC) and
normal controls (NC). The relationship between Tregs
subpopulations and clinical factors was analyzed.
Materials and methods
Tregs were analyzed in 40 patients with GC and in
17 NC. Tregs were detected by multicolor flow cytome-
try based on CD4+CD25highFoxP3+ phenotype. The
expressions of CD45RA (naive Tregs), HLA-DR (marker
of activation), CD62L (L-selectin) and CD39 (marker of
homing to inflamed regions) were investigated. The data
was analyzed with STATISTICA 10 software by Mann–
Whitney U test and Spearman’ correlation test.
Results
The percentages of circulating Tregs were similar in
patients with GC and in NC (6.1% vs 5.2%, P>0.1), but
the mean absolute number of Tregs was higher in NC
compared to patients with GC (47 cells/µl vs 32 cells/µl,
P < 0.1).
In addition, the frequency and the absolute number of
Treg positive for CD45RA, HLA-DR and CD62L were
greater in NC than in GC patients (P < 0.001). There
were no correlations between the percentages of Tregs
and clinical factors. However, the absolute number of
Tregs (r=0.34) and their subpopulations expressing
HLA-DR (r=0.32), CD62L (r=0.4) and CD39 (r=0.33)
significantly correlated with higher risk of lymph nodes
metastasis.
Conclusions
Subpopulations of Tregs were differed between GC
patients and NC. Surprisingly, percentages of Tregs
expressing CD45RA, HLA-DR and CD62L were lower
in GC patients. However, we observed correlation
between the absolute number of Tregs subpopulations
and disease stage. Further investigation should be taken
to assess the prognostic value of Tregs subpopulations.
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